REAL-LIFE EFFECTIVENESS OF NATALIZUMAB IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS): A REGISTRY ANALYSIS

被引：0
|
作者：
Danko, D. [1 ]
Manca, A. [2 ]
Mor, Z. [3 ]
Csepany, T. [4 ]
机构：
[1] Corvinus Univ Budapest, Budapest, Hungary
[2] Univ York, York YO10 5DD, N Yorkshire, England
[3] Ideas Solut, Budapest, Hungary
[4] Univ Debrecen, H-4012 Debrecen, Hungary
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.334
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND3
引用
收藏
页码：A56 / A57
页数：2
相关论文
共 50 条
  • [11] Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study
    Ilki, Canan Duman
    Gunduz, Tuncay
    Kurtuncu, Murat
    Yapici, Zuhal
    Sencer, Serra
    Eraksoy, Mefkure
    TURKISH JOURNAL OF NEUROLOGY, 2020, 26 (01) : 34 - 38
  • [12] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 640 - 640
  • [13] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    SWISS MEDICAL WEEKLY, 2016, 146 : 80S - 80S
  • [14] Real-life long-term effectiveness of fingolimod in Swiss patients with relapsing-remitting multiple sclerosis
    Zecca, C.
    Roth, S.
    Findling, O.
    Perriard, G.
    Bachmann, V.
    Pless, M. L.
    Baumann, A.
    Kamm, C. P.
    Lalive, P. H.
    Czaplinski, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (05) : 762 - 767
  • [15] Real-life long-term effectiveness of fingolimod in a Swiss relapsing-remitting multiple sclerosis cohort
    Zecca, Chiara
    Roth, Serge
    Findling, Oliver
    Perriard, Guillaume
    Bachmann, Valerie
    Pless, Misha L.
    Baumann, Andreas
    Kamm, Christian P.
    Lalive, Patrice H.
    Czaplinski, Adam
    NEUROLOGY, 2017, 88
  • [16] Real-world safety and effectiveness of natalizumab treatment in patients with relapsing-remitting multiple sclerosis: data from an Irish registry
    McGuigan, C.
    Kinirons, P.
    Ryan, A.
    Moore, H.
    Murphy, S. M.
    Hennessy, M.
    Gibson, B.
    Hayden, B.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 299 - 300
  • [17] SALIVARY CORTISOL AND FATIGUE IN EVERYDAY LIFE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS)
    Moss-Morris, R.
    Powell, D.
    Liossi, C.
    Schlotz, W.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2014, 21 : S59 - S59
  • [18] COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN RUSSIA
    Matveev, N., V
    Sabanov, A., V
    Luneva, A., V
    VALUE IN HEALTH, 2014, 17 (03) : A60 - A60
  • [19] Cerebellar information processing in relapsing-remitting multiple sclerosis (RRMS)
    Lesage, E.
    Apps, M. A. J.
    Hayter, A. L.
    Beckmann, C. F.
    Barnes, D.
    Langdon, D. W.
    Ramnani, N.
    BEHAVIOURAL NEUROLOGY, 2010, 23 (1-2) : 39 - 49
  • [20] A simple mathematical model for relapsing-remitting multiple sclerosis (RRMS)
    Elettreby, M. F.
    Ahmed, E.
    MEDICAL HYPOTHESES, 2020, 135
12345